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THE generation of nitrite (NOr) was used as an index
of the production of nitric oxide by human and rat
polymorphonuclear leukocytes (PMN) and rat peritoneal
macrophages. Human peripheral blood PMN did not
produce significant levels of NOr. Attempts to induce
NOr generation in human PMN by incubation with
GM-CSF (1 nM), TNFt (0.3 nM), endotoxin (1 Itg/ml) or
formyl-Met-Leu-Phe (100 nM) for up to 16 h were not
successful. Addition of human PMN primed by GM-CSF
(1 nM) to rabbit aortic ring preparations precontracted
with phenylephrine had no effect on tone. In contrast to
these observations, PMN, isolated from the peritoneum of
oyster glycogen treated rats, generated NOr via a
pathway sensitive to inhibition by the nitric oxide synthase
inhibitor, NG-monomethyl L-arginine. However, peri-
pheral blood rat PMN obtained from the same animals
did not produce NO-, even during prolonged incubation
for periods of up to 16 h. It is suggested that detectable
NO production by PMN requires NO synthase activity to
be induced either by the process ofPMN migration or by
exposure to certain cytokines produced locally at the site
of inflammation.
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Introduction
Nitric oxide (NO) is a relatively long-lived free
radical (half-life of 3-5 s) which is identical to, or
is the active component of, endothelium derived
relaxing factor. 1’2 It is claimed that NO has
significant roles in haemostasis, regulation of
systemic blood pressure, neurotransmission and
immune responses. 3’4 Many of the physiological
actions of NO appear to be mediated by activation
of soluble guanylate cyclase,
4 whereas the cytotoxic
activities in host defence responses appear to
involve toxic interactions with Fe-S proteins. 5’6
NO biosynthesis has been reported to occur in a
variety of cell types including endothelial cells,
vascular smooth muscle cells,
8 adrenal gland
cells,
9 Kupffer cells,l cerebellar neurones,
11
macrophages
12 and polymorphonuclear leukocytes
(PMN).
1>16 It has recently been suggested that the
NO synthase in PMN may represent a third type of
isozyme which is intermediate between that of the
inducible form and the calcium/calmodulin de-
pendent constitutive form. 17’18 It is not clear
whether the neutrophil enzyme is inducible or con-
stitutive, but its activity appears to be independent
of calcium/calmodulin. Much of the evidence for
NO generation by PMN has come from bioassay
studies. Co-incubation of rat elicited PMNs with
platelets was found to significantly inhibit platelet
aggregation irrespective of the stimulus for
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aggregation. 14’19 The inhibitory activity was pre-
vented by the preincubation ofPMNs with the NO
synthase inhibitor, L-NMMA or oxyhaemoglobin,
which binds and inactivates NO, suggesting that
the inhibitory factor was NO. These results are in
contrast to those of Schattner and coworkers2 who
found that the inhibition of platelet aggregation by
co-incubation of human PMN with platelets was
not prevented by oxyhaemoglobin, suggesting that
the inhibition of platelet aggregation was not due
to neutrophil derived NO.2 Moreover, it has
recently been suggested that platelets themselves
may generate NO, and this endogenous NO may
modulate platelet activity.
21 PMN derived NO has
been measured by chemiluminescence,ls’1 a techni-
que which detects inorganic NO- as well as
NO.
22 In addition, human PMN NO generation has
been measured indirectly by a spectrophotometric
assay based on the reaction of the Griess reagent
with NO-, one of the stable NO decay products,
which provides an index ofNO generation. Wright
and coworkers1 demonstrated that unstimulated
human peripheral blood PMNs were capable of
generating a high basal level of NO-.
16 Further-
more, the capacity of human peripheral blood
PMN to generate NO is reported to be
stimulated acutely by formyl methionyl leucyl
phenylalanine (fMLP).
is However, Keller et al.
23
did not observe significant NO production in
activated PMN. Clearly, there are unresolved
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discrepancies in the reported generation of NO by
PMN, which may relate to both the methods of
detection ofNO and the means of activation of the
neutrophils.
In the present study the authors have examined
whether human peripheral blood PMN generate
significant amounts of NO- under basal con-
ditions. A range of potential stimuli for PMN NO-
production, including granulocyte macrophage
colony stimulating factor (GM-CSF), tumour
necrosis factor (TNF-x) and endotoxin have also
been examined. In addition, in rat elicited PMN the
dependence of this NO- generation on protein
synthesis and the relationship of NO synthesis to
extravasation of neutrophils were investigated.
Isolated peritoneal macrophages, which produce
large amounts of NO-, were used to establish the
sensitivity of the assay of NO- as an index of NO
generation.
Materials and Methods
All reagents used in this study were of analytical
grade or higher. Endotoxin (E. coli lipopolysacchar-
ride serotype Oll B4), fMLP, penicillin-G, cyclo-
heximide, oyster glycogen (Type 2), bovine serum
albumin (cell culture tested, BSA, fraction 5),
dextran T-500, Tyrode’s salts (cell culture grade,
endotoxin tested. Composition: HEPES 5 mM,
NaC1 137 mM, D-glucose 11 mM, NaHCO3 11.9
mM, KC1 2.7 mM, MgCI2 0.26 mM and CaC12
1.8 mM), HEPES buffer (N-2-hydroxyethylpiper-
azine-N-2-ethane sulphonic acid), cytochrome-c,
nitro-L-arginine, superoxide dismutase, zymosan
and sodium bicarbonate were all purchased from
Sigma Chemical Co., St Louis, MO, USA. TNF-
was a generous gift from Dr G. Adolf,
Boehringer Ingleheim, Germany. GM-CSF was a
generous gift from Dr M. Railings, Scher-
ing-Plough Pty Ltd, Sydney, Australia. Other
reagents were purchased from the following
sources: RPMI-1640 pH 7.4 with L-glutamine and
without phenol red (Commonwealth Serum Labor-
atories, Parkville, Australia); phosphate buffered
saline salts (Oxoid, England). All media were
prepared in pyrogen-free water for injection
(B.P.) (Travenol Laboratories Pty. Ltd, N.S.W.,
Australia); NG-monomethyl-L-arginine (L-NMMA)
(Calbiochem-Behring Corp., La Jolla, CA,
USA); nitro-iminoethyl-L-ornithine (L-NIO, IDT,
Victoria, Australia); sodium citrate (Mallinckrodt);
Ficoll-Hypaque (Pharmacia, Sweden); pentobarbi-
tone (Bomac Laboratories, N.S.W., Australia) and
heparin sulphate (porcine mucous) from Fisons P/L
N.S.W., Australia).
Isolation of human peripheral blood PMN: Bully coats
were supplied by the Red Cross blood bank, South
Melbourne, Australia. PMN were isolated by
dextran sedimentation of red blood cells and density
gradient centrifugation through lymphoprep (5 ml)
according to methods described previously in
detail. 24’2s The isolated cells were stained with
gentian violet and counted in an haemocytometer
which indicated that > 98% were PMN according
to morphology and that greater than 99% of the
cells were viable according to trypan blue exclusion.
The PMN were resuspended in either Tyrode’s
buffer pH 7.4, phosphate buffered saline or phenol
red free RPMI 1640 (each containing 0.25% BSA)
at a concentration ranging from 2-50 x 106 per ml.
Since no differences were observed in the level of
NO- generated under these diterent incubation
conditions, the results have been pooled.
Isolation of rat elicited PMNs and macrophages Peritoneal
macrophages were isolated from rats according to
previously described methods.
26 Briefly, male
Sprague-Dawley rats (150-300g) received an
injection of oyster glycogen dissolved in phosphate
buffered saline (PBS, 10ml, 2%, i.p.). Oyster
glycogen prepared at this concentration did not
contain detectable endotoxin (less than 100 pg/ml),
as measured by the limulus amoebocyte lysate assay
(E-toxate, Sigma). After 16-20 h the rats were killed
by a blow to the head. PBS (50 units/ml heparin,
30-40 ml) was injected into the peritoneal cavity.
The peritoneum was gently massaged for I min and
the lavage fluid was aspirated and centrifuged
(1000 xg-, 4c, 5min). The cell pellet was
resuspended in Tyrode’s buyer pH 7.4 (5 ml) and
underlayered with lymphoprep (5 ml). The cell
suspension was centrifuged (1 000 x E, 4C, 20
min), and the mononuclear ceils were obtained from
the interface between the saline and the lymphoprep
solution. The mononuclear cell suspension was
centrifuged (100 x g, 4C, 10 min) and an aliquot
was then counted in a haemocytometer. The
suspension was found to be > 98% mononuclear by
gentian violet staining and 99% viable by trypan
blue exclusion. The cells were resuspended at a
concentration of 1 x 106/ml in RPMI 1640 (without
phenol red, containing 0.25% BSA). One-ml
aliquots of the isolated peritoneal lavage cells were
dispensed into 24-well tissue culture plates. After a
2 h adherence period, the non-adherent cells were
removed by aspiration.
The cell pellet from the lymphoprep separation
containing PMN was resuspended in Tyrode’s
buffer pH 7.4 (20 ml) and centrifuged (1 000 x g,
4C, 5 min). The washing procedure was repeated
once and an aliquot was stained with the gentian
violet. The suspension was found to be >98%
PMN. The PMNs were resuspended at a concen-
tration of 2 x 106/ml in Tyrode’s buffer pH 7.4.
Rat peripheral blood PMN: Rats were anaesthetized
with pentobarbitone (60-90mg/kg) given sub-
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cutaneously and exsanguinated by cannulation of
the carotid arteries. The blood was slowly drawn
into a 10 ml syringe (containing 1 ml of sodium
citrate, 3.8% w/v) and the PMN were isolated from
red blood cells by dextran sedimentation and
further isolated as described for human PMN.
Rabbit isolated aortic rings: Adult rabbits of either sex
were anaesthetized by intravenous administration
of saffan (3-5 ml, Glaxo Animal Health Ltd,
Melbourne, Australia) and killed by exsanguination.
Rings either with or without an intact endothelium
were prepared and mounted in 5 ml organ baths in
Krebs’ bicarbonate solution as described pre-
viously.
27
Determination of PMN and macrophage NO synthesis:
Aliquots of purified PMN (2-50 x 106/ml) from
human or rat peripheral blood, or of elicited rat
PMN from peritoneal lavage fluid were pipetted
into sterile tubes and pretreated with either the NO
synthase inhibitor L-NMMA (100/M)
14 or the
protein synthesis inhibitor cycloheximide (12
/,g/ml) for 50min. Tyrode’s buffer, endotoxin
(1 #g/ml), GM-CSF (1 nM) or rhTNF- (0.3 nM)
was added and the PMN suspensions were
incubated for 1-24 h at 37C with gentle rocking
through 45 at 22 times per min to prevent
adherence. In some experiments, either buffer or
fMLP (100 nM) was added during the final 5 min
of incubation, the cell supernatants were obtained
by centrifugation (1 000 x g,, 4C, 5min) and
stored at -20C until analysis. Adherent macro-
phages were pretreated in an identical manner.
Spectrophotometric assay of nitrite: Nitrite levels from
PMN or macrophage supernatants were measured
using the reaction of the Griess reagent (1%
sulphanilamide/0.1% napthylethylenediamine dihy-
drochloride/2.5% phosphoric acid) with NO-
forming a chromophore that absorbs at 546 nm.
28
Briefly, 250/,1 of sample was added to 250/,1 of
freshly prepared Griess reagent. Following a 5 min
period to allow colour development, the absorbance
was determined in a spectrophotometer (Hitachi
Ui000). The concentration of NO- was quan-
tified by comparison with a standard curve
constructed using known concentrations of NO-
(10-100 #M). A 0.1% solution ofNO was made by
injecting NO gas (130/1) from a gas tight syringe
into a 13 ml glass vial containing distilled water
which had been thoroughly degassed by continuous
bubbling with helium for 30 min. The solution was
then left open to the atmosphere for 30min
ensuring that all the NO had decayed to NO- and
NO-. This 0.1% solution of NO was divided into
aliquots at concentrations of 10-100/,M and
assayed at 546nm, which indicated that the
proportion of NO that had decayed to NO- was
30% at 100/tM, but this decreased to 14% in a
10/,M solution.
Superoxide anion assay" The generation of superoxide
anion (O-) was measured by the superoxide
dismutase inhibitable reduction of cytochrome-c
according to our previous studies,is Following
50 min pretreatment with L-NMMA (100 #M) or
the vehicle, 0.25% BSA in Tyrode’s buffer, PMNs
were suspended at 1-2 x 106/ml in Tyrode’s buffer
containing 80 #M cytochrome-c and stimulated
with fMLP for 5 min or zymosan (400 #g/ml) for
60 min. The absorbance of the cell-free supernatants
was determined in an Hitachi Ui000 spectrophoto-
meter. The generation of O- was calculated by
the superoxide dismutase (30U/ml) inhibitable
change in absorbance at 550nm using the
differential molar extinction coefficient, 21 x 103
M-1 cm -1.
Statistical analyses: All data are expressed as
mean + standard error of the mean (S.E.M.) of n
observations. The comparison of the generation of
NO- between the control and treated groups
were analysed for statistical significance using
Student’s paired t-test. Ap value less than 0.05 was
considered to be statistically significant.
Results
Rat peritoneal macrophage NO generation: Macrophages
isolated from rats previously treated with 2% oyster
glycogen generated levels of NO- which were
detectable for 2 h of incubation and continued to
increase up to 24h (Table 1). In peritoneal
macrophages obtained from untreated animals
(resident macrophages) the synthesis of NO- was
not apparent during the first 16 h of incubation, but
reached a level similar to that of elicited
macrophages after 24 h of incubation. The NO-
generation was inhibited by L-NMMA (100/M)
(p < 0.05, paired t-test) by between 36% and 66%
in the various treatment groups (Table 1).
Pretreatment of elicited macrophages with cyclo-
heximide (12#g/ml) reduced NO- generation
(p < 0.05, paired t-test) by approximately 70%
(Table 1). Investigation of the relative potencies of
L-NMMA and L-NIO as inhibitors of the
generation of NO- by resident macrophages
revealed that L-NIO was considerably more
potent and had a greater peak effect at the highest
concentrations tested (Fig. 1).
Human peripheral blood PMN: A low NO- level was
detected in supernatants obtained from human
peripheral blood PMN that were incubated at 37C
for 1 h. However, the NO- level did not increase
significantly in supernatants from cells incubated
for a further 15h (Table 2). In addition,
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Table 1. Generation of NO by rat peritoneal macrophages
Concentration of
NO- (nmol/106 cells)
Control L-NMMA (100 #M)
Incubation mean -t- S.E.M.) (mean -I- S.E.M.)
Cells time (h) Treatment (n) (n)
Resident macrophages
Elicited macrophages
16 None 0.38 _+ 0.1 0.04 _+ 0.0"
(3) (3)
24 None 19.4 + 4.2 11.4 + 3.4*
(5) (5)
16 None 9.2 __+ 1.5 4.9 -I- 1.6*
(3) (3)
24 None 34.7 ___
10.6 22.5 + 7.1
(4) (4)
24 Endotoxin 38.6 -I- 11.9 25.3 -t- 10.0"
(1 #g/ml) (4) (4)
24 Cycloheximide 11.8 + 3.9** ND
(12 #g/ml) (4)
p < 0.05 Student’s paired t-test, compared with the corresponding value in the absence of L-NMMA.
p< 0.05 Student’s paired t-test, compared with the control value obtained after 24h incubation of
elicited macrophages.
N D, not done.
pretreatment with L-NMMA (100 #M) had no
significant effect on the apparent NO- generation
(Table 2). Incubation of human PMN with
endotoxin (1 #g/ml), rhTNF (0.3 nM), rhGM-CSF
or fMLP (100 nM) have been shown previously to
achieve maximal priming of PMN functions
including the respiratory burst.24 Therefore, human
peripheral blood PMN were incubated with the
optimal concentrations of these priming agents for
1 to 16 h and stimulated with fMLP for 5 min at
the end of this pre-incubation period. No L-NMMA
sensitive NO- generation was observed in PMN
treated with these stimuli (Table 2). In freshly
isolated human PMN, incubation with L-NMMA
140
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FIG. 1. Effects of pre-incubation with the L-arginine analogues, L-NMMA
and L-NIO on the generation of NO by rat resident peritoneal
macrophages. The results are presented as the means and standard
errors of the means of four observations. The control level of NO
detected in this 24 h incubation was 24.7 6.3 nmol/106 cells. ,
L-NIO; , L-NMMA.
352 Mediators of Inflammation. Vol 2.1993
(100 #M) or nitro-L-arginine (NOLA, 100 #M) had
no effect on the superoxide anion generation in
response to either fMLP (100nM) or zymosan
(400 #g/ml) (Table 3).
Vasoactive effects ofhumanperipheral bloodPMN: In rabbit
aortic rings denuded of endothelium and pre-
co.ntracted with 0.1 mM phenylephrine, addition of
5 x 106 PMN had no significant effect (-6.4 __+
3.0%, n 4) on tone, whereas sodium nitroprusside
(10 #M) reduced the phenylephrine induced tone by
101 + 1%. The addition of PMN treated with
GM-CSF (1 nM, 60 min) to the organ bath also had
no effect on the tone of phenylephrine contracted
preparations. By comparison, in aortic preparations
containing an intact endothelium, acetylcholine
(3 M) reduced the phenylephrine induced tone by
73+ 11%.
NO generation by rat peripheral blood and elicitedperitoneal
PMN: Detectable amounts of NO- were observed
in supernatants obtained from rat elicited PMNs
after 2h incubation and increased further up
to 16 h (Table 4). Pretreatment of rat elicited PMNs
with L-NMMA (100 #M) inhibited NO- produc-
tion by approximately 60% (p < 0.05, paired t-test),
whereas pretreatment with cycloheximide (12
#g/ml) had no inhibitory effect on NO- generation
(Table 4). Endotoxin (1 #g/ml) caused a small
increase in the amount of NO- generated
by rat elicited PMN.
In contrast to elicited PMN, cells obtained from
the peripheral blood of the same animals (i.e. those
treated with oyster glycogen, i.p.) did not generateNeutrophils and nitric oxide
Table 2. Generation of nitrite by human PMN and its inhibition by L-NMMA (100 #M)
Amount of NO- generated (nmol/106 cells)
h 2h 16h
Control L-NMMA Control L-NMMA Control L-NMMA
(mean _+ S.E.M.) (mean _+ S.E.M.) (mean _+ S.E.M.)
Treatment n n n
Control 0.08 _
0.04 0.15 _+ 0.06 0.11 _+ 0.07 0.10 -t- 0.03
8 8 8 8
Endotoxin 0.20 _+ 0.11 0.14 _+ 0.04 0.13 0.06
(1 /g/ml) 4 4 2 2
rhTNF 0.07 _+ 0.04 0.07 _
0.03 0.05 0.07
(0.3 nM) 4 3 2 2
fMLP 0.05 _+ 0.03 0.05 ___
0.3 0.04 0.05
(100 nM) 3 3 2 2
rhGM-CSF 0.08 0.08 ND ND
(1 nM) 2 2
0.30 _+ 0.11 0.23 _+ 0.05
14 14
0.26 -t- 0.09 0.29 _
0.09
8 8
0.26 _+ 0.08 0.21 _+ 0.05
10 10
0.29 _+ 0.07 0.25 _+ 0.07
10 10
0.19 _+ 0.02 0.18 _+ 0.04
3 3
Table 3. Effects of NO synthase inhibitors on superoxide anion generation by human PMN
Amount of superoxide anion generated (nmol/106 cells)
Control L-NMMA 100 #M Control NOLA 100 #M
Stimulus mean _+ S.E.M. (n) mean _
S.E.M. (n) mean _
S.E.M. (n) mean _+ S.E.M. (n)
fMLP (100 nM) 5.50 _+ 2.24 (4) 5.68 _
1.45 (4) 5.17 _
1.39 (5)
Zymosan (400 #g/ml) 5.65 __+ 1.54 (5) 5.59_ 1.32 (5) ND
N D, not done.
5.07 _
1.84 (5)
ND
Table 4. Generation of NO- by peripheral blood and peritoneal elicited PMN
Concentration of
NO- (nmol/108 cells)
Control L-NMMA (100/M)
Incubation (mean -t- S.E.M.) (mean _
S.E.M.)
Cells time (h) Treatment (n) (n)
Elicited PMN None 0.22 _
0.14 0.21 _
0.16 (NS)
(4) (4)
2 None 0.23 -I- 0.09 0.19 __+ 0.1 (NS)
(4) (4)
16 None 1.76 _+ 0.45 0.71 _+ 0.24*
(10) (10)
16 Endotoxin 2.84 -I- 0.84 1.64 -I- 0.48*
(8) (8)
16 Cycloheximide 1.83 _
0.38 ND
(12 #g/ml) (6)
Peripheral blood PMN 16 None 0.09 _+ 0.07
(4)
0.07 -I- 0.07 (NS)
(4)
p < 0.05, paired Student’s t-test, compared with the value obtained in the absence of L-NMMA.
NS, not significant.
N D, not done.
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significant levels of NO-. The low level of
absorbance detected in the Griess reaction in these
supernatants was not inhibitable by L-NMMA
(100 #M). Similarly, peripheral blood PMN from
untreated rats failed to generate detectable amounts
of NO- during a 16 h incubation.
Discussion
The present results indicate that human peri-
pheral blood PMNs do not generate detectable
levels of NO- during prolonged incubation.
Furthermore, untreated PMN and those primed by
GM-CSF did not show any NO-like bioactivity
when co-incubated with pre-contracted rabbit
aortic strips. The spectrophotometric assay did
detect NO- production by rat elicited neutrophils
and by macrophages, but there was no significant
generation of NO- by rat peripheral blood PMN.
In macrophages and rat elicited neutrophils, the
sensitivity of the NO- production to inhibition
by L-NMMA confirmed that the NO- was
produced via the NO synthase pathway.
The assay used in these studies detects NO-
concentrations as low as 0.1 nmol, a level similar to
that observed in human neutrophils incubated for
short periods.
29 However, there was no time-
dependent increase in NO- production and the
NO synthase inhibitor, L-NMMA had no inhibitory
effect. These findings suggest that the apparent
NO- levels detected may represent a nonspecific
reaction of the Griess reagent or NO- production
by another metabolic pathway. NO- generated by
either rat elicited PMNs or macrophages was
inhibited by incubation with L-NMMA or L-NIO
(100 #M). Experiments in other cell types, includ-
ing cytokine activated endothelial cells, indicate that
concentrations of L-NMMA as high as 300/M are
30 31 required for near complete inhibition and that
L-NIO is considerably more potent than L-NMMA.
Some of the difference in potency between these
inhibitors of NO synthase may be explained by
competition with L-arginine in the medium for
uptake into the cell.
The failure to detect significant levels of NO-
in human peripheral blood PMN contrasts with the
findings of Wright and coworkers. 16 However, in
the latter study the origin of the material reacting
with the Griess reagent was not confirmed by the
use of NO synthase inhibitors. Furthermore,
phosphate buffered saline (PBS) was used as the
incubation medium, whereas in our studies several
media were used, including RPM1 1640, Tyrode’s
buffer and PBS; L-NMMA sensitive production of
NO- by PMN was not observed in any of these
incubation media.
Bioassay experiments have demonstrated that rat
PMNs elicited into the peritoneal cavity are capable
of generating NO-like biological activity as
measured by an inhibition of platelet aggregation.
14
Studies by Rimele and co-workers
13 provided
evidence of a neutrophil derived vasorelaxant which
had properties indistinguishable from those of
NO. Further studies by this group indicated that
the rat elicited neutrophils generate at least ten-fold
higher levels of nitrite that human peripheral blood
neutrophils.
29 The present study has confirmed and
extended these observations by showing that the
NO- production in rat elicited neutrophils is
reduced by NO synthase inhibitors and that more
prolonged incubation of human neutrophils (up to
24 h) does not lead to accumulation of significant
levels of NO-.
In vitro protein synthesis does not appear to be a
requirement for NO- production by PMN, since
cycloheximide had no effect on NO- generation
by elicited PMN. However, cycloheximide did
reduce the NO- generation by rat macrophages,
indicating that continuing protein synthesis, in vitro,
is required for the production ofNO by these cells.
This differential sensitivity to cycloheximide sug-
gests that NO synthase of PMN is induced in vivo
and persists in vitro, whereas the macrophage NO
synthase may turn over more rapidly and further
synthesis in vitro is required.
The difference in the ability of rat elicited PMN
and human peripheral blood PMN to generate
NO- may represent a species difference. How-
ever, in rat peripheral blood PMN from either
untreated animals or from those which received
oyster glycogen 24 h earlier, there was no L-NMMA
sensitive NO- generation, even during prolonged
incubation. Thus, these findings support the
suggestion that the elicitation process itself may be
the stimulus for induction of the NO synthase,
29
which has been isolated from rat elicited neu-
trophils.
17 Alternatively, cytokine exposure during
the neutrophil extravasation rather than the
migration across the blood vessel wall may be the
inducing stimulus. IFN-y and endotoxin have been
shown to induce the macrophage NO synthase.32’3
Attempts to induce NO- generation using
endotoxin and other agents including GM-CSF,
TNF or fMLP were not successful. Further work
is required to investigate which combination, if any,
of cytokines and other inflammatory mediators is
required to produce NO synthase in PMN. There
is some agreement in the literature that the NO
synthase inhibitors do not affect the cytostatic
activity of peripheral blood PMN,2’34 which
contrasts with the discordant results regarding
PMN generation of NO. It is likely that the levels
of NO required for cytostasis and for detection as
NO- are higher than those which are detected in
bioassays such as platelet aggregation. Physiological
roles of PMN derived NO may be restricted to
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regulation of function of adjacent platelets14’35 or to
locomotion of PMN themselves
36 rather than the
cytotoxic role that has been established for
macrophages which produce much higher amounts
of NO.
It has been suggested that NO might regulate the
respiratory burst, but this effect is observed only at
very high concentrations.
37 The authors’ studies
indicate that high concentrations of NO, which are
supramaximal for relaxation of isolated arteries,
reduce fMLP induced superoxide anion generation
by only 20% and NO does not augment the
inhibitory effects of PGE2 .38 Moreover, we have
now shown that NO synthase inhibition in
peripheral blood humanPMN does not significantly
affect superoxide anion production. Thus, an
autocrine role for NO in the regulation of the
respiratory burst in circulating PMN is unlikely.
PMN that have migrated into exudates have a
higher capacity to produce superoxide anion than
those in the circulation.39’4 Both superoxide anion
and NO have been ascribed important roles in host
defence as cytotoxic agents. Recently, it has been
suggested that the co-production of NO and
superoxide anion in an acidic environment, such as
that likely to be encountered at an inflammatory or
ischaemic site, may result in the formation of
peroxynitrite which decays to the highly reactive
hydroxyl radical.41’42 The requirement for induction
of NO synthase and for priming of the respiratory
burst may serve to restrict the capacity of PMN to
generate such highly toxic radical species until these
cells reach sites of inflammation.
In summary, we find no evidence that peripheral
blood PMN generate detectable levels of NO-,
but activation of PMN during extravasation does
appear to induce an NO synthase. The NO thus
produced may have important roles at inflammatory
sites.
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